← Eichor
Study identifier: NCT07273058 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effect of HIIT on Post-Stroke Fatigue

Condition: Stroke  ·  Sponsor: The Hong Kong Polytechnic University

PhaseNA
Planned participants60
Who can joinAll sexes, 40 Years to 80 Years
Healthy volunteersNo

About this study

This study aims to investigate the effect of high-intensity interval training (HIIT) on fatigue severity among individuals with chronic stroke. Participants will be randomly assigned to the HIIT group, the moderate-intensity continuous training (MICT) group, or the stretching group (active control). Each group will participate in supervised exercise sessions three times per week over a 12-week period, totaling 36 sessions. Outcome assessments will be conducted at baseline, mid-intervention (week 6), post-intervention (week 12), and follow-up (week 20). The primary outcome will be fatigue severity. Secondary outcomes will include inflammatory biomarkers and additional health-related indicators.

This description comes directly from the study's public registry record.

Talk to the study team

Mei Zhen Prof. Huang  ·  +852 00000000  ·  mei-zhen.huang@polyu.edu.hk

Fong Sze Chung  ·  fschung@polyu.edu.hk

Always discuss trial participation with your own doctor first.

Locations (1)

The Hong Kong Polytechnic UniversityKowloon, Hong KongRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07273058